ALEC (Alector Inc.) Kompaniyaning sof aktivlari

Ommaviy kompaniya Alector Therapeutics (ALEC) logotipi

Alector, Inc. (ALEC) neyrodegenerativ patologiyalar terapiyasi bilan shug'ullanadi. GURU.Markets platformasidagi bozor narxi vizualizatsiyasi kotirovkalarni -0.01 darajasida ko'rsatmoqda, firma moliyaviy barqarorligi esa hozirda sinov xarajatlari tufayli tashqi investitsiyalarga tayanmoqda. Innovatsion immuno-neyrologiya metodi kasallikka qarshi kurashish uchun mikrogliyani rag'batlantiradi, ammo narx belgilash imkoniyati faqat klinik sinovlardan keyin paydo bo'ladi. Bundan tashqari, Alector, Inc. (ALEC) molekulalarni tanlashni tezlashtirish uchun avtomatlashtirilgan laboratoriyalarni joriy qilmoqda.

ALEC Alector Therapeutics Balans kapitallashuvi (04.07.2022 - 27.10.2026)

Alector Therapeutics (ALEC) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Birja narxi Alector, Inc.|ALEC - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi Alector Inc.|ALEC - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Alector|ALEC - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti alector.com|ALEC - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Alector, Inc.|ALEC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Alector, Inc.|ALEC - Kompaniya qarzlari|Balans qiymatiga qarzlar Alector Inc.
Kompaniyaning jamlanma tahlili:ALEC - Alector
alector.com yetakchi tovari

Alector, Inc. miyadan toksinlarni tabiiy ravishda tozalash uchun antitanachalar ishlab chiqish orqali immunonevrologiya innovatsiyalaridan foydalanadi. Ushbu ishlanmalarning samaradorligi qarz majburiyatlarini hisobga olmaganda, sof aktiv qiymatiga bevosita ta'sir qiladi. Ushbu ko'rsatkich spekulyativ narxlar shovqinidan xoli holda, aksiyadorlar ixtiyoridagi haqiqiy kapitalni o'lchaydi. Tashkilotning kitob kapitalizatsiyasi tahlili biznesning fundamental barqarorligini ochib beradi. Ushbu kitob kapitalizatsiyasidagi tendentsiya resurslarni boshqarish sifatidan dalolat beradi.

Alector, Inc. raqobatchilari tahlili

BIIB - Kompaniyaning xususiy kapitali|NBIX (Neurocrine Biosciences) - Balans kapitallashuvi|RGC (regencellbioscience.com) - Kompaniyaning sof aktivlari|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|TRVI (Trevi Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi PRAX|Kompaniyaning balans qiymati Anavex Life Sciences Corp. (AVXL)|Kompaniyaning balans qiymati CeriBell Inc (CBLL)|PRTA: Balans kapitallashuvi|Kompaniyaning xususiy kapitali Annexon Biosciences Inc. ANNX|OMER: Balans kapitallashuvi|neurogene.com (NGNE) - Kompaniyaning sof aktivlari|ACIU - Kompaniyaning sof aktivlari|VYGR (Voyager Therapeutics Inc) - Jami sof aktivlar|Kompaniyaning balans qiymati NMRA (Neumora Therapeutics Inc)|Kompaniyaning xususiy kapitali SCLX|Tevogen Bio Holdings (TVGN) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati alphacognition.com ACOG|Kompaniyaning sof aktivlari Cognition Therapeutics|Kompaniyaning buxgalteriya qiymati Inhibikase Therapeutics Inc IKT|Balans kapitallashuvi SAVA (Cassava)|ASRT: Biznesning balans bahosi|Kompaniyaning balans qiymati coyatherapeutics.com|Vistagen (VTGN) - Buxgalteriya kapitallashuvi|Balans kapitallashuvi OVID|Kompaniyaning sof aktivlari Acumen Pharmaceuticals Inc. (ABOS)|CRVO (CervoMed Inc) - Kompaniyaning sof aktivlari|Biznesning balans bahosi alteritytherapeutics.com (ATHE)|Balans kapitallashuvi CLNN (Clene)|PepGen Inc - Balans kapitallashuvi|JUNS - Kompaniyaning balans qiymati|RLMD - Kompaniyaning balans qiymati|Balans kapitallashuvi ANVS|Grace Therapeutics (GRCE) - Kompaniyaning xususiy kapitali|Balans kapitallashuvi AIFF|Kompaniyaning sof aktivlari KLTO|Kompaniyaning balans qiymati NeuroSense Therapeutics NRSN|Buxgalteriya kapitallashuvi Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA: Balans kapitallashuvi|NRXS - Kompaniyaning xususiy kapitali|Helius Medical Technologies Inc. - Kompaniyaning sof aktivlari|PASG: Balans kapitallashuvi|Kompaniyaning balans qiymati bionomics.com.au NEUP|NERV (Minerva Neurosciences Inc) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati ATHA (Athira)|Kompaniyaning xususiy kapitali Addex|Balans kapitallashuvi ALZN|Balans kapitallashuvi CYCN (cyclerion.com)|Kompaniyaning balans qiymati Protagenic Therapeutics, Inc. PTIX|Kompaniyaning balans qiymati Pasithea Therapeutics Corp KTTA|CRGT (Cortigent Medical) - Balans kapitallashuvi|ATXI - Kompaniyaning xususiy kapitali|BCLI (Brainstorm Cell) - Balans kapitallashuvi|Kompaniyaning sof aktivlari caratherapeutics.com|Chromocell Therapeutics Corp. (CHRO) - Kompaniyaning sof aktivlari|Jami sof aktivlar ELYM|Intra-Cellular Therapies - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali LBPH (Longboard)|Kompaniyaning balans qiymati Marinus Pharmaceuticals|NKGN - Kompaniyaning buxgalteriya qiymati|Kompaniyaning sof aktivlari NeuroBo Pharmaceuticals, Inc. (NRBO)|SAGE - Kompaniyaning buxgalteriya qiymati|Neurotrope - Balans kapitallashuvi|TRVN (Trevena Inc) - Biznesning balans bahosi|Kompaniyaning balans qiymati Vigil Neuroscience Inc. (VIGL)|Buxgalteriya kapitallashuvi Anew Medical Inc.|Balans kapitallashuvi CERE (Cerevel Therapeutics, Inc.)